United Therapeutics Corporation
UTHR
$300.60
-$1.81-0.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.71% | 17.22% | 19.72% | 22.89% | 19.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.71% | 17.22% | 19.72% | 22.89% | 19.85% |
| Cost of Revenue | 12.60% | 26.89% | 6.90% | 18.54% | 21.37% |
| Gross Profit | 11.60% | 16.05% | 21.39% | 23.46% | 19.67% |
| SG&A Expenses | 19.65% | 17.80% | 25.32% | 20.77% | 36.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.90% | 28.06% | 5.80% | 20.64% | 39.53% |
| Operating Income | 13.94% | 7.44% | 38.55% | 24.83% | 2.07% |
| Income Before Tax | 14.95% | 6.25% | 34.22% | 10.46% | 6.00% |
| Income Tax Expenses | 28.11% | 10.11% | 21.58% | -5.58% | 1.58% |
| Earnings from Continuing Operations | 11.29% | 5.09% | 38.78% | 15.51% | 7.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.29% | 5.09% | 38.78% | 15.51% | 7.29% |
| EBIT | 13.94% | 7.44% | 38.55% | 24.83% | 2.07% |
| EBITDA | 13.88% | 8.43% | 38.81% | 25.57% | 3.77% |
| EPS Basic | 9.56% | 10.00% | 45.93% | 21.46% | 13.33% |
| Normalized Basic EPS | 14.40% | 14.21% | 57.13% | 33.40% | 11.31% |
| EPS Diluted | 9.57% | 7.46% | 42.09% | 18.77% | 11.64% |
| Normalized Diluted EPS | 14.28% | 11.58% | 52.82% | 30.27% | 9.81% |
| Average Basic Shares Outstanding | 1.58% | -4.47% | -4.89% | -4.90% | -5.33% |
| Average Diluted Shares Outstanding | 1.68% | -2.21% | -2.21% | -2.62% | -4.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |